Results 21 to 30 of about 491,575 (216)
Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
Clinical Medicine Insights: Oncology, 2021 Background: The number of cases of cervical cancer with recurrence and peritoneal carcinomatosis is limited. In our study, we aimed to present the results of cytoreductive surgery hyperthermic intraperitoneal chemotherapy treatment and its 3-year early ...
Ozgul Duzgun, Murat Kalin
doaj +1 more source
Сибирский онкологический журнал, 2022 Gastric cancer (gc) is one of the most common cancers worldwide. The majority of newly diagnosed gastric cancer cases present with distant metastases. Peritoneal carcinomatosis (pc) is the most unfavorable type of progression of primary gc, which occurs ...
V. A. Markovich +10 more
doaj +1 more source
Pleura and Peritoneum, 2022 Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis.
Casella Francesco +10 more
doaj +1 more source
Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]
, 2014 The role of systemic chemotherapy (SC) in conjunction with cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in appendiceal mucinous carcinoma peritonei (MCP) is ...
Blackham, Aaron U. +19 more
core +1 more source
Primary ovarian high-grade endometrial stromal sarcoma: a case report
Journal of Medical Case Reports, 2021 Background Primary ovarian high-grade endometrial stromal sarcoma is a very rare disease. Even though it has poor prognosis, the gold standard treatment has not been established owing to its rarity.
Ji Sun Lee +5 more
doaj +1 more source
, 2022 This is a systematic review of the literature to evaluate the current literature on the use of Hyperthermic Intraperitoneal Chemotherapy in treating women with pelvic cancer and to report on the added ...
Toni Horton +2 more
core +1 more source
World Journal of Surgical Oncology, 2020 Background Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy.
Natasha Leigh +6 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2023 Despite extensive treatment with surgery and chemotherapy many patients with peritoneal metastases from colorectal cancer experience intraperitoneal disease relapse. The α-emitting 224 radium-labelled microparticle radionuclide therapeutic Radspherin® is
Ebbe Billmann Thorgersen MD, PhD +6 more
doaj +1 more source
Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer [PDF]
Chinese Clinical Oncology, 2020 Epithelial ovarian cancer (EOC), has the highest worldwide mortality of all gynecological tumors, in 75% of cases is diagnosed in advanced stages. Despite of treatments with maximal cytoreductive surgery (CRS) and platinum-based chemotherapy (CT), approximately 70% of patients with advancedstage disease relapse within 18 months, given this high number ...
Juan Manuel, Medina-Castro +1 more
openaire +2 more sources
Pleura and Peritoneum, 2022 Two surgical techniques used for peritoneal metastasis involve a risk of exposure to antineoplastic drugs (ADs): hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Benoist Hubert +8 more
doaj +1 more source